Serum Binding of Diltiazem in Humans
Authors:
- 1 April 1982
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 22 (4) , 201-205
Abstract
Diltiazem binding was measured by equilibrium dialysis in the serum of five healthy male subjects, aged 22 to 34 years, at seven serum diltiazem concentrations ranging from 0.03 to 2.06 μg/ml. The percentage of unbound diltiazem ranged from 19.6 ± 3.1 to 22.6 ± 4.1 (mean ± S.D.) and was independent of serum diltiazem concentration. Serum diltiazem binding was also examined in the presence of six drugs that might be used concurrently with diltiazem in patients being treated for cardiac disease. The percentage of unbound diltiazem was not influenced by digoxin, hydrochlorothiazide, phenylbutazone, propranolol, salicylic acid, or warfarin at therapeutic concentrations of these drugs over the therapeutic range of diltiazem.Keywords
This publication has 7 references indexed in Scilit:
- Clinical Pharmacokinetics of DiureticsClinical Pharmacokinetics, 1980
- Clinical Pharmacokinetics of PropranololClinical Pharmacokinetics, 1979
- Protein Binding of Cardiac Glycosides in Disease StatesClinical Pharmacokinetics, 1977
- Plasma and Tissue Protein Binding of Drugs in PharmacokineticsDrug Metabolism Reviews, 1976
- Plasma protein binding of tricyclic anti-depressants in manBiochemical Pharmacology, 1969
- The binding of salicylate to plasma proteins in different speciesJournal of Pharmacy and Pharmacology, 1967
- THE PHYSIOLOGICAL DISPOSITION OF PHENYLBUTAZONE (BUTAZOLIDIN) IN MAN AND A METHOD FOR ITS ESTIMATION IN BIOLOGICAL MATERIALThe Journal of Pharmacology and Experimental Therapeutics, 1953